Survey of clinical practice: growth hormone use during illness.
Prior to the 1999 National Cooperative Growth Study (NCGS) meeting, a postal card survey was conducted of the NCGS investigators about their current practices regarding continuation of growth hormone (GH) therapy during intercurrent illnesses. The survey results were subsequently compared with responses to the same questions obtained from NCGS investigators who attended lectures at the NCGS meeting describing the physiology and effects of GH in critically ill patients. Comparing results from the two surveys, there were no observed differences in the responses with respect to practices relative to the intercurrent illnesses treated at home. The percentage of NCGS investigators who indicated that they would stop GH treatment during more serious illnesses was greater following attendance at the lectures.
August
G P
GP
The George Washington University, Department of Endocrinology and Metabolism, Children's National Medical Center, Washington, DC 20810-2970, USA.
Lightner
E S
ES
Root
A W
AW
D015897:Comorbidity; D003625:Data Collection; D006130:Growth Disorders / Q000150:complications / Q000188:drug therapy*; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D010818:Practice Patterns, Physicians'
D013006:Growth Hormone